Giuseppe Caruso, Medical Consultant at The European Institute of Oncology, shared:
“Honoured to be speaking at ESGO2027 in London!
I am truly grateful to join the scientific session ‘Key Innovations from Clinical ENGOT Trials during 2026’, alongside Prof. Isabelle Ray-Coquard and Prof. Philipp Harter.
2026 has been a remarkable year for ENGOT trials. I look forward to discussing what these results really mean for our patients and our daily practice.
Reminder: abstract submission for ESGO 2027 closes on 30 October 2026. Don’t miss the chance to share your research and join us in London!
It’s going to be an amazing congress, and you will find the ENYGO family there.
See you there!”
Christina Fotopoulou, Consultant Gynaecologic Oncologist at Charité University Hospital of Berlin, shared Giuseppe Caruso’s post on LinkedIn, adding:
“Great to have you there Giuseppe!”
_____
ESGO 2027 is the 28th European Congress on Gynaecological Oncology, scheduled to take place from February 25 to 27, 2027, in London, United Kingdom.
Under the guiding theme of ‘Bridging Science & Care,’ the ESGO 2027 congress is set to deliver an impactful and comprehensive program. Attendees can look forward to exploring the latest scientific breakthroughs alongside live surgical updates from leading experts in the field.
The event will also feature interactive debates, multi-disciplinary tumor boards, and hands-on workshops, including dedicated sessions on robotic surgery. Furthermore, this year’s congress will highlight important structural advancements in research with the formal introduction of a new Code of Conduct for Diversity in clinical trials.
_____
You can also read:
Registrations Open for the ESGO 2027 Awareness Run and Walk in London
